Home › Funds › EMERALD ADVISERS, LLC › CORT
EMERALD ADVISERS, LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
EMERALD ADVISERS, LLC reported holding 758,257 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$87.4M, representing 2.40% of its reported portfolio and ranking #2 among its reported holdings. EMERALD ADVISERS, LLC has disclosed CORT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EMERALD ADVISERS, LLC's CORT position evolved
EMERALD ADVISERS, LLC first disclosed a stake in CORT in Q1 2025 at 62,182 shares (US$7.1M). The position peaked in Q3 2026 at 758,257 shares, worth US$87.4M. Across 7 filings, EMERALD ADVISERS, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 758,257 shares valued at US$87.4M — an increase of 9,932 shares quarter over quarter.. Notable position changes include a 289% increase in Q2 2025 (shares rose 13% over the following quarter), a 264% increase in Q2 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 62.18K | $7.10M | New |
| Q2 2025 | 242.05K | $17.77M | Add |
| Q3 2025 | 232.45K | $19.32M | Reduce |
| Q4 2025 | 232.74K | $8.10M | Hold |
| Q1 2026 | 205.56K | $8.29M | Reduce |
| Q2 2026 | 748.33K | $65.07M | Add |
| Q3 2026 | 758.26K | $87.37M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$558.9M), Parallel Advisors, LLC (US$449.7M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 4.85M sh · $558.88M · Q3 2026
- Parallel Advisors, LLC 3.90M sh · $449.69M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 473.88K sh · $54.61M · Q3 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on EMERALD ADVISERS, LLC
FAQ
How long has EMERALD ADVISERS, LLC held CORT?
EMERALD ADVISERS, LLC has disclosed CORT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is EMERALD ADVISERS, LLC's current position in CORT?
As of Q3 2026, EMERALD ADVISERS, LLC holds 758.26K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $87.37M, representing 2.40% of its reported portfolio and ranking #2.
Has EMERALD ADVISERS, LLC been buying or selling CORT?
In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in CORT. The position peaked in Q3 2026 at 758.26K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.